Skip to content
10-Q

Quarterly Report

Pulmonx Corp LUNG

0001127537-26-000025

← back to feed
Filed
May 4, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 27, 2026 42.24M sh
Shares Diluted Q1 2026 · Mar 31, 2026 41.9M sh
Shares Diluted Q1 2026 · Mar 31, 2025 39.95M sh
Capex Q1 2026 · Mar 31, 2026 $9K
Capex Q1 2026 · Mar 31, 2025 $301K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$10.1M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$13.22M
Long Term Debt Q1 2026 · Mar 31, 2026 $37.21M
Long Term Debt Q1 2026 · Dec 31, 2025 $36.99M
Short Term Debt Q1 2026 · Mar 31, 2026 $104K
Short Term Debt Q1 2026 · Dec 31, 2025 $106K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $61.57M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $69.75M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $74.56M
Stockholders Equity Q1 2026 · Mar 31, 2026 $45.76M
Stockholders Equity Q1 2026 · Dec 31, 2025 $54.12M
Stockholders Equity Q1 2026 · Mar 31, 2025 $77.67M
Stockholders Equity Q1 2026 · Dec 31, 2024 $85.81M
Current Liabilities Q1 2026 · Mar 31, 2026 $18.91M
Current Liabilities Q1 2026 · Dec 31, 2025 $20.06M
Total Liabilities Q1 2026 · Mar 31, 2026 $74.21M
Total Liabilities Q1 2026 · Dec 31, 2025 $75.18M
Current Assets Q1 2026 · Mar 31, 2026 $92.75M
Current Assets Q1 2026 · Dec 31, 2025 $101.68M
Total Assets Q1 2026 · Mar 31, 2026 $119.97M
Total Assets Q1 2026 · Dec 31, 2025 $129.29M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.33
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.36
Eps Basic Q1 2026 · Mar 31, 2026 −$0.33
Eps Basic Q1 2026 · Mar 31, 2025 −$0.36
Sga Expense Q1 2026 · Mar 31, 2026 $24.1M
Sga Expense Q1 2026 · Mar 31, 2025 $26.15M
Rd Expense Q1 2026 · Mar 31, 2026 $4.9M
Rd Expense Q1 2026 · Mar 31, 2025 $4.76M
Net Income Q1 2026 · Mar 31, 2026 −$13.65M
Net Income Q1 2026 · Mar 31, 2025 −$14.45M
Operating Income Q1 2026 · Mar 31, 2026 −$12.96M
Operating Income Q1 2026 · Mar 31, 2025 −$14.56M
Gross Profit Q1 2026 · Mar 31, 2026 $16.04M
Gross Profit Q1 2026 · Mar 31, 2025 $16.34M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $4.54M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $6.2M
Revenue Q1 2026 · Mar 31, 2026 $20.59M
Revenue Q1 2026 · Mar 31, 2025 $22.54M